Keywords: Dementia, PET/MR
Motivation: This study investigates the use of [11C]CS1P1 PET imaging to assess neuroinflammation as an early biomarker of cerebral small vessel disease (cSVD) and Alzheimer’s Disease (AD).
Goal(s): The goal of this study is to assess whether [11C]CS1P1 uptake correlates with cSVD or AD burden.
Approach: The overall approach of this study is a prospective cross-sectional analysis correlating [11C]CS1P1 to white matter hyperintensity (WMH) burden and PiB Centiloid.
Results: Among 23 participants, results showed a correlation between WMH burden and [11C]CS1P1 PET uptake in both normal appearing white matter and gray matter, suggesting its utility in identifying high-risk areas for disease progression.
Impact: [11C]CS1P1 PET could be a biomarker of early AD and cSVD. This imaging approach could guide the timely application of disease-modifying therapies and possibly enhancing treatment outcomes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords